ask="55.00"
ask_size="1000"
average_daily_volume="915518"
bid="52.50"
bid_size="100"
book_value="10.71"
change="+0.21"
change_from_200_day_moving_average="6.10"
change_from_50_day_moving_average="7.83"
change_from_52_week_high="-25.63"
change_From_52_week_low="23.10"
change_in_percent="+0.39%"
close="54.48"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.08"
eps_estimate_next_quarter="-1.31"
eps_estimate_next_year="-4.69"
ex_dividend_date="N/A"
float_shares="71077000"
high="55.69"
high_52_weeks="80.11"
last_trade_date="3/16/2017"
last_trade_price="54.48"
last_trade_size="46316"
last_trade_time="4:00pm"
low="53.25"
low_52_weeks="31.38"
market_capitalization="4.69B"
moving_average_200_day="48.38"
moving_average_50_day="46.65"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="66.40"
open="54.21"
pe_ratio="N/A"
peg_ratio="-0.23"
percent_change_from_200_day_moving_average="+12.61%"
percent_change_from_50_day_moving_average="+16.78%"
percent_change_from_52_week_high="-31.99%"
percent_change_from_52_week_low="+73.61%"
previous_close="54.27"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.07"
price_per_sales="98.98"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="11.04"
stock_exchange="NMS"
symbol="ALNY"
volume="1248818"
weeks_range_52="31.38 - 80.11"
